Literature DB >> 19368607

Increased macrophage migration inhibitory factor in Behçet's disease and relation with the disease activity.

G Serarslan, S Söğüt, Z Yönden, H Oksüz, N Savas, J Z Yenin, A Arpaci.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19368607     DOI： 10.1111/j.1468-3083.2009.03223.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN： 0926-9959            Impact factor:   6.166


× No keyword cloud information.
  2 in total

Review 1.  Outcome measures used in clinical trials for Behçet syndrome: a systematic review.

Authors:  Gulen Hatemi; Peter A Merkel; Vedat Hamuryudan; Maarten Boers; Haner Direskeneli; Sibel Z Aydin; Hasan Yazici
Journal:  J Rheumatol       Date:  2014-02-01       Impact factor: 4.666

2.  Macrophage Migration Inhibitory Factor -173GC Variant Might Increase the Risk of Behçet's Disease.

Authors:  Ayse Feyda Nursal; Serbulent Yigit; Ercan Tural; Goknur Kalkan; Mehmet Kemal Tumer; Akin Tekcan
Journal:  Med Princ Pract       Date:  2018-04-18       Impact factor: 1.927
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.